Home
/
Evolent Health, Inc.
/
Financials
/
Quarterly
Evolent Health, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Evolent Health, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2021
Sep 30, 2021
$222.47M
Nov 4, 2021
Q2
2021
Jun 30, 2021
$222.06M
Aug 5, 2021
Q3
2021
Sep 30, 2020
$239.57M
Nov 4, 2021
Q2
2021
Jun 30, 2020
$217.30M
Aug 5, 2021
Q1
2018
Mar 31, 2018
$139.71M
May 10, 2018
Q1
2018
Mar 31, 2017
$106.24M
May 10, 2018
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$479.53M
Nov 7, 2025
Q2
2025
Jun 30, 2025
$444.33M
Aug 11, 2025
Q1
2025
Mar 31, 2025
$483.65M
May 9, 2025
Q3
2025
Sep 30, 2024
$621.40M
Nov 7, 2025
Q2
2025
Jun 30, 2024
$647.15M
Aug 11, 2025
Q1
2025
Mar 31, 2024
$639.65M
May 9, 2025
Q3
2024
Sep 30, 2023
$511.02M
Nov 8, 2024
Q2
2024
Jun 30, 2023
$469.14M
Aug 9, 2024
Q1
2024
Mar 31, 2023
$427.69M
May 10, 2024
Q3
2023
Sep 30, 2022
$352.59M
Nov 2, 2023
Q2
2023
Jun 30, 2022
$319.94M
Aug 3, 2023
Q1
2023
Mar 31, 2022
$297.06M
May 4, 2023
Q3
2022
Sep 30, 2021
$222.47M
Nov 3, 2022
Q2
2022
Jun 30, 2021
$222.06M
Aug 3, 2022
Q1
2022
Mar 31, 2021
$215.07M
May 5, 2022
Q3
2020
Sep 30, 2020
$264.59M
Nov 6, 2020
Q2
2020
Jun 30, 2020
$238.63M
Aug 7, 2020
Q1
2020
Mar 31, 2020
$247.29M
May 28, 2020
Q3
2020
Sep 30, 2019
$220.14M
Nov 6, 2020
Q2
2020
Jun 30, 2019
$191.96M
Aug 7, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($20.86M)
Nov 7, 2025
Q2
2025
Jun 30, 2025
($19.90M)
Aug 11, 2025
Q1
2025
Mar 31, 2025
($64.62M)
May 9, 2025
Q3
2025
Sep 30, 2024
($23.14M)
Nov 7, 2025
Q2
2025
Jun 30, 2024
$1.60M
Aug 11, 2025
Q1
2025
Mar 31, 2024
($17.28M)
May 9, 2025
Q3
2024
Sep 30, 2023
($25.32M)
Nov 8, 2024
Q2
2024
Jun 30, 2023
($34.32M)
Aug 9, 2024
Q1
2024
Mar 31, 2023
($19.98M)
May 10, 2024
Q3
2023
Sep 30, 2022
$2.12M
Nov 2, 2023
Q2
2023
Jun 30, 2022
($4.59M)
Aug 3, 2023
Q1
2023
Mar 31, 2022
($5.35M)
May 4, 2023
Q3
2022
Sep 30, 2021
($13.04M)
Nov 3, 2022
Q2
2022
Jun 30, 2021
($9.11M)
Aug 3, 2022
Q1
2022
Mar 31, 2021
($9.81M)
May 5, 2022
Q3
2020
Sep 30, 2020
($37.35M)
Nov 6, 2020
Q2
2020
Jun 30, 2020
($203.52M)
Aug 7, 2020
Q1
2020
Mar 31, 2020
($78.75M)
May 28, 2020
Q3
2020
Sep 30, 2019
($25.52M)
Nov 6, 2020
Q2
2020
Jun 30, 2019
($31.62M)
Aug 7, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$886.0K
Nov 7, 2025
Q2
2025
Jun 30, 2025
($1.17M)
Aug 11, 2025
Q1
2025
Mar 31, 2025
($1.62M)
May 9, 2025
Q3
2025
Sep 30, 2024
($16.27M)
Nov 7, 2025
Q2
2025
Jun 30, 2024
$7.79M
Aug 11, 2025
Q1
2025
Mar 31, 2024
($13.41M)
May 9, 2025
Q3
2024
Sep 30, 2023
($17.94M)
Nov 8, 2024
Q2
2024
Jun 30, 2023
($21.57M)
Aug 9, 2024
Q1
2024
Mar 31, 2023
($10.36M)
May 10, 2024
Q3
2023
Sep 30, 2022
$12.95M
Nov 2, 2023
Q2
2023
Jun 30, 2022
($4.63M)
Aug 3, 2023
Q1
2023
Mar 31, 2022
($2.80M)
May 4, 2023
Q3
2022
Sep 30, 2021
($6.58M)
Nov 3, 2022
Q2
2022
Jun 30, 2021
($7.67M)
Aug 3, 2022
Q1
2022
Mar 31, 2021
($15.95M)
May 5, 2022
Q3
2021
Sep 30, 2020
($16.45M)
Nov 4, 2021
Q2
2021
Jun 30, 2020
($225.83M)
Aug 5, 2021
Q1
2020
Mar 31, 2020
($25.50M)
May 28, 2020
Q3
2020
Sep 30, 2019
($20.14M)
Nov 6, 2020
Q2
2020
Jun 30, 2019
($25.23M)
Aug 7, 2020